T. Rowe Price Investment Management’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-715,968
Closed -$31.4M 651
2024
Q3
$31.4M Buy
715,968
+19,470
+3% +$855K 0.02% 473
2024
Q2
$27.4M Sell
696,498
-519,805
-43% -$20.4M 0.02% 472
2024
Q1
$52.1M Sell
1,216,303
-95,892
-7% -$4.11M 0.03% 390
2023
Q4
$53.5M Sell
1,312,195
-259,482
-17% -$10.6M 0.03% 386
2023
Q3
$79.2M Buy
1,571,677
+917,161
+140% +$46.2M 0.06% 289
2023
Q2
$27.2M Buy
654,516
+56,408
+9% +$2.34M 0.02% 449
2023
Q1
$14.2M Buy
+598,108
New +$14.2M 0.01% 495